Reynolds Vuse E-Cigarette Market Share Increases, Juul Ranking 2rd

Business by { "type": "", "title": "", "logo": "", "description": "", "auth": "", "seo_url": "" }

Nov.20.2023

Reynolds Vuse E-Cigarette Market Share Increases, Juul Ranking 2rd

According to Journalnow, Reynolds Tobacco's Vuse e-cigarette market share increases to 42.1%, surpassing Juul's 24.4%.

According to a recent report by Journalnow, Reynolds Tobacco's e-cigarette brand Vuse has seen a slight increase in market share, rising to 42.1%. This surpasses the second-ranked Juul, which has maintained a market share of 24.4%.

Meanwhile, the market share of NJoy, a subsidiary of Altria Group and ranked number three, has not significantly increased, remaining at 2.5%.

In addition, Altria and British American Tobacco warn that the prevalence of illegal synthetic nicotine e-cigarettes is increasing in the American market. According to estimates by both companies, these illicit synthetic e-cigarette products represent approximately half of the domestic market share in the United States.

According to reports, this report covers a four-week period from the previous report until November 4th. Nielsen's data for this report mostly comes from major retail chains.

References:

[1] Reynolds' Vuse slightly expands US e-cigarette market lead

Also Read:

[1] VUSE Maintains Leading Position in Market Share, JUUL Declines

[2] Vuse E-cigarette's Market Share Drops Slightly but Remains on Top

#vuse #Juul #Reynolds #E-cigarette #E-cigarettes and Tobacco #E-cigarette Market

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model

The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.

Regulations

Dec.20 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia

Alfabet Labs, the parent company of FLONQ, has recently launched its new vaping brand ROQY in Russia, debuting two products: ROQY L and ROQY M. Both devices use a hybrid nicotine formulation combining nicotine salts and freebase nicotine and are each available in 19 flavors. The two products are now on sale via the official ROQY website as well as multiple online and offline retailers across Russia.

Nov.19 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake

As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.

Nov.03 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation